Humana price target raised to $400 from $385 at RBC Capital

RBC Capital raised the firm’s price target on Humana to $400 from $385 and keeps an Outperform rating on the shares. The firm is updating its model after the company’s Q2 results as well as to reflect the management’s more recent discussion of seasonal considerations for the second half of this year, the analyst tells investors in a research note. The commentary eased fears of continued step-up in inpatient volume following recent commentary from hospital operators of sequentially stronger two-midnight admissions, the firm added.